Baxter International To Collaborate With Tel Aviv University

Baxter International said early Thursday it is partnering with Tel Aviv University (TAU) to evaluate and help bring the early-stage research to commercialization technologies currently under development at the university and at el Aviv Sourasky Medical Center (TASMC).

Under terms of the agreements, Baxter will exclusively license the TAU Technology Innovation Momentum Fund technology in one license agreement and TAU and TASMC technology in the second license agreement for use in multiple potential applications that might result from the joint research activity. Baxter, TAU and TASMC plan to explore potential applications of multiple projects that target large, unmet needs that, if successful, will expand Baxter’s portfolio of products into new areas of surgical care for the company.

Leave a Comment